Chronic Prostatitis
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bristol Myers SquibbThalidomide
Hua MedicineTUDP
Dr. Reddy's LaboratoriesLevofloxacin 500
Clinical Trials (3)
Total enrollment: 689 patients across 3 trials
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
Start: Mar 2006Est. completion: Nov 20069 patients
Phase 2Terminated
Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis
Start: Jan 2020Est. completion: Dec 2021180 patients
N/AUnknown
Non Interventional Study of Levofloxacin in Chronic Prostatitis
Start: Jul 2013Est. completion: Mar 2014500 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.